Based on the known mechanisms of action of BET/EP300 inhibition in other cancers (i.e. MYC pathways inhibition) and that at least part of the UPS showed an enrichment of MYC targets, we hypothesized that targeting BET/EP300 proteins in UPS might be an interesting strategy. This evidence concerns the gene EP300 and cancer.